Clinical Trial: A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus
Study Status: Completed
Recruit Status: RECRUITING
Condition: Diabetes Mellitus, Type 1
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Randomized, Placebo-Controlled, 2-Period, Cross-over, Double- Blind, Single-Dose Study to Evaluate the Effects of LY3532226 on Insulin- Induced Hypoglycemia in Participants With Type 1 Diab
Brief Summary:
The main purpose of this study is to evaluate the response of glucagon to insulin-induced low blood sugar after administration of the study drug LY3532226 in participants with type 1 diabetes mellitus (T1DM).The study will also evaluate if LY3532226 helped participants to recover from insulin-induced low blood sugar condition compared to placebo.The study will last approximately 16 weeks excluding screening period.
Read more